학술논문
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
Document Type
Article
Author
Pouyiourou, Maria; Kraft, Bianca N.; Wohlfromm, Timothy; Stahl, Michael; Kubuschok, Boris; Löffler, Harald; Hacker, Ulrich T.; Hübner, Gerdt; Weiss, Lena; Bitzer, Michael; Ernst, Thomas; Schütt, Philipp; Hielscher, Thomas; Delorme, Stefan; Kirchner, Martina; Kazdal, Daniel; Ball, Markus; Kluck, Klaus; Stenzinger, Albrecht; Bochtler, Tilmann
Source
Nature Communications; 10/24/2023, Vol. 14 Issue 1, p1-21, 21p
Subject
Language
ISSN
20411723
Abstract
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)